UPDATE : Thursday, July 18, 2019
Huons to build new office
Huons Global said Wednesday that it plans to move its headquarters and R&D ...
by Lee Han-soo  |  2017-09-15 10:29
Daewoong wins rights to market hepatitis B treatment
Daewoong Pharmaceuticals대웅제약 (President Lee Jong-wook이종욱) said Thursday tha...
by Constance Williams  |  2017-09-14 19:37
NOAC race: Pradaxa prescription numbers fall behind fast followers
The first product to gain indications for a disease often maintains a domin...
by Marian Chu  |  2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose?
Two blockbuster immunotherapies Opdivo and Keytruda gained insurance covera...
by Marian Chu  |  2017-09-14 17:54
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon  |  2017-09-14 17:53
AstraZeneca regains momentum with positive Imfinzi results
Astra Zeneca Korea said Thursday it had some good news from its phase 3 Pac...
by Marian Chu  |  2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea
Amgen Korea said it signed a joint promotion agreement with Korean pharmace...
by Marian Chu  |  2017-09-13 18:33
Alvogen Korea to sell Vivus’ obesity drug
Alvogen Korea said Wednesday that it gained exclusive marketing rights to s...
by Marian Chu  |  2017-09-13 18:16
ASEAN officials visit JW’s manufacturing plant
Officials involved in good manufacturing practice (GMP) in 10 member nation...
by Song Soo-youn  |  2017-09-13 18:07
Opdivo’s expanded indications ease cancer patients’ worries
Ono Pharma Korea and Bristol-Myers Squibb said Wednesday that their blockbu...
by Marian Chu  |  2017-09-13 16:57
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon  |  2017-09-13 15:55
Brokerage analyzes profit-sharing structure of Celltrion group
Local stock analysts’ eyes are now on the profit-sharing structure of the C...
by Nam Doo-hyun  |  2017-09-12 16:55
EU approves Abbvie’s Humira as first biologic to treat CHMP
Abbvie Korea, the Korean offshoot of the global biopharmaceutical company, ...
by Marian Chu  |  2017-09-12 15:45
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon  |  2017-09-12 14:34
Lilly’s diabetes drug ahead of Novo Nordisk’s in Q2 market share
Lilly Korea’s diabetes drug Trulicity grabbed the largest market share in K...
by Marian Chu  |  2017-09-12 13:26
Sillajen stock surges upon clinical trial announcement
The share price of Sillajen, a biopharmaceutical company, has been surging ...
by Lee Han-soo  |  2017-09-12 13:26
Ildong, Olix agree to develop new drugs
Ildong Pharmaceutical and Olix Pharmaceuticals, an RNA interference (RNAi)-...
by Lee Han-soo  |  2017-09-11 17:30
Abbvie lands 1st place on Dow Jones Sustainability Index
Global biopharmaceutical Abbvie said Monday it has ranked number one, for t...
by Marian Chu  |  2017-09-11 14:38
GSK’s HIV drug ranked No. 1 in Q2 sales
GlaxoSmithKline (GSK) said Monday its human immunodeficiency virus (HIV) tr...
by Marian Chu  |  2017-09-11 14:37
FDA orders halt on Opidvo trials
Two months after the U.S. Food and Drug Administration halted Merck & Co’s ...
by Marian Chu  |  2017-09-08 16:39
Back to Top